Array of cutaneous adverse effects associated with sorafenib
Authors:
- Heidi H. KongHKHeidi H. Kong
- Maria L. TurnerMTMaria L. Turner
- 1 August 2009
- journal article
- other
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 61 (2) , 360-361
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Hand-Foot Skin Reaction Increases with Cumulative Sorafenib Dose and with Combination Anti-Vascular Endothelial Growth Factor TherapyClinical Cancer Research, 2009
- Dermatologic symptoms associated with the multikinase inhibitor sorafenibJournal of the American Academy of Dermatology, 2009
- Prospective Study of the Cutaneous Adverse Effects of Sorafenib, a Novel Multikinase InhibitorArchives of Dermatology, 2008
- Sorafenib-Induced Eruptive Melanocytic LesionsArchives of Dermatology, 2008
- Leukocytoclastic Vasculitis Masquerading as Hand-Foot Syndrome in a Patient Treated With SorafenibArchives of Dermatology, 2006